Skip to content

Author

B. Veeraraghavan

We have 3 of 407 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Evaluation of Sequential Phage-Antibiotic Therapy Reveals Enhanced Biofilm Control with Meropenem and Colistin in Clinical MDR Hypervirulent Klebsiella pneumoniae Strain.

Sequential phage-antibiotic treatment was effective against MDR-HvKp biofilms, with pre-phage exposure enhancing antibiotic access through biofilm disruption, and the bacteriostatic nature of tigecycline reduced efficacy by affecting phage replication.

R. Juliet, Madhumathi Irulappan, B. Veeraraghavan et al. · 0 citations
Open access Jul 2026

A low resource requirement molecular diagnostic and surveillance tool for Shigella in the era of vaccination

A nine-target multiplex PCR lateral flow device assay for the rapid, accurate identification of vaccine-prioritised S. flexneri serotypes, as well as clinically relevant antimicrobial resistance genes, is presented.

F. Khokhar, Xiao-Liang Ba, Charlotte E. Chong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.